指南与共识头颈与中枢神经肿瘤

ASCO认可ASTRO口咽鳞癌放疗循证指南

Radiation Therapy for Oropharyngeal Squamous Cell Carcinoma: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline.
指南 / 共识 · J Clin Oncol · 2017-10-24

ASCO对ASTRO于2017年7月发布的OPSCC放疗循证指南进行方法学严谨性与临床准确性评估,决定予以认可并补充少量限定说明。推荐覆盖根治性放疗联合系统治疗、术后放疗±系统治疗、诱导化疗及剂量分割与体积方案,涉及多分期与临床场景。

要点

  • ASCO认可ASTRO关于OPSCC放疗的循证指南并补充少量限定说明
  • 推荐涉及根治性放疗加系统治疗、术后放疗±系统治疗及诱导化疗
  • 指南引用AJCC分期第7版,覆盖多分期与临床场景的剂量分割与体积方案

核心结论

  • ASCO专家组认定ASTRO指南推荐清晰、全面且基于最相关科学证据,决定予以认可并加入少量限定说明。

研究设计与样本

  • ASCO内容专家评估临床准确性、方法学家评估制定严谨性,认可后召开专家组审议并由临床实践指南委员会批准最终认可。
  • 所认可指南为ASTRO于2017年7月发布的OPSCC放疗循证指南。

主要发现

  • ASCO专家组认为ASTRO指南推荐清晰、全面且基于最相关科学证据。
  • ASCO认可该指南并补充了少量限定说明和对ASTRO推荐的小幅修改。

关键数值与推荐

  • 推荐涵盖根治性放疗联合系统治疗、原发手术后术后放疗±系统治疗、诱导化疗,以及放疗剂量、分割与体积方案(±系统治疗),适用于多种疾病分期与临床场景。
  • 指南引用的分期系统为AJCC分期手册第7版。

临床怎么用

  • ASCO认可ASTRO的OPSCC放疗推荐,临床可参照该指南并注意ASCO补充的限定说明与小幅修改。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Purpose The American Society for Radiation Oncology (ASTRO) produced an evidence-based guideline on radiation therapy in oropharyngeal squamous cell carcinoma (OPSCC) that was determined to be relevant to the American Society of Clinical Oncology (ASCO) membership. After applying standard critical appraisal policy and endorsement procedures, ASCO chose to endorse the ASTRO guideline. Methods The ASTRO guideline was reviewed by ASCO content experts for clinical accuracy and by ASCO methodologists for developmental rigor. On favorable review, an ASCO Expert Panel was convened to review the guideline contents and recommendations. The ASCO guideline approval body, the Clinical Practice Guidelines Committee, approved the final endorsement. Results The ASCO Expert Panel determined that the ASTRO guideline recommendations, published in July 2017, are clear, thorough, and based upon the most relevant scientific evidence. ASCO endorsed the ASTRO guideline and added minor qualifying statements. Recommendations Recommendations for the addition of systemic therapy to definitive radiotherapy in the treatment of OPSCC, postoperative radiotherapy with and without systemic therapy following primary surgery of OPSCC, induction chemotherapy in the treatment of OPSCC, and the appropriate dose, fractionation, and volume regimens with and without systemic therapy in the treatment of OPSCC are outlined for a variety of disease stages and clinical scenarios. ASCO Endorsement Panel qualifying statements and minor modifications were made to the ASTRO recommendations. The staging system that is referenced in these guidelines is the American Joint Committee on Cancer Staging Manual, 7th edition. Additional information is available at: www.asco.org/head-neck-cancer-guidelines and www.asco.org/guidelineswiki .

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Quon H, Vapiwala N, Forastiere A, et al. Radiation Therapy for Oropharyngeal Squamous Cell Carcinoma: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline. J Clin Oncol. 2017. PMID: 29064744. doi:10.1200/JCO.2017.73.8633

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。